Peter Winkley

Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.

Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada.

The Canadian Shipowners Mutual Assurance Association insure candadian ships against war risk. It offers insurance by the government of canada and by the standard steamship owners' mutual war risk association limited. The company was founded in 1953 and is headquartered in Toronto, Canada.

The North of England Protecting & Indemnity Association Ltd. provides marine insurance services. It offers protection and indemnity insurance, freight demurrage, defense, and war risk coverage services to 3100 merchant ships worldwide. The company was founded in 1886 and is headquartered in Newcastle-upon-Tyne, UK.